The proposal builds on innovative technologies patented and published by my group. The project has two specific objectives: 1) to deliver the new generation of intelligent biomedical devices that have the capacity to control infections, inflammation and foreign body response; and 2) to develop a novel, non-invasive and affordable point of care diagnostic technology for early detection of chronic kidney diseases, and kidney and bladder cancers that is much needed in this space of healthcare.
Identifying Patient-centred Outcomes For People With Chronic Kidney Disease And Translating Them Into Policy And Practice
Funder
National Health and Medical Research Council
Funding Amount
$463,652.00
Summary
This 4 year fellowship project engages with patients, caregivers, clinicians, researchers and policy makers, to establish core outcomes and outcome measures in dialysis and transplantation. This will ensure that patient-centred outcomes are consistently measured and reported in dialysis and transplantation trials and other forms of research.
The Ethics And Politics Of Pharmaceutical Innovation And Translation
Funder
National Health and Medical Research Council
Funding Amount
$476,728.00
Summary
I lead a research program on the ethics and politics of pharmaceutical innovation and translation: how medicines are developed, regulated, funded and taken up into practice. I aim to help policymakers to deal with conflicts among stakeholders. Over the next 4 years I will conduct a suite of research projects on topics of immediate significance to Australian policymakers; develop a new framework for pharmaceutical ethics and create a “Pharmaceutical Ethics and Politics Network.”